About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

Contraceptive Drugs Market

Contraceptive Drugs Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

Contraceptive Drugs Market by Product (Oral (Combined Contraceptives, Progestin-only Pills), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels & NGOs, Others), by North America (U.S., Canada) Forecast 2026-2034

Feb 19 2025

Base Year: 2025

180 Pages

Contraceptive Drugs Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

Key Insights

The Contraceptive Drugs Market size was valued at USD 17.50 USD billion in 2023 and is projected to reach USD 29.41 USD billion by 2032, exhibiting a CAGR of 7.7 % during the forecast period. Contraceptive drugs are drugs that are premeditated to prohibit pregnancy by counteracting follicular inhibitions, changing cervical mucus thickness, or disrupting the influx of sporozoites or fetus fixation. There are several kinds of such contraception agents: COC containing estrogen and progesterone, POP, injectables, patches, and implants. COCs work in a way that reduces the release of FSH and LH which are responsible for ovulation whereas POPs make the cervical mucus thick such that the sperm cannot penetrate. Fertility control medicines such as Depo-Provera contain progestin, which either blocks conception or prevents the passage of sperm. Oral pills and injectables are other forms of EC that release hormonal agents in a controlled manner to inhibit pregnancy. But this group of products is not limited to birth control: it covers menstrual regulation, acne management, and reduction of the heaviness of menstruation.

Contraceptive Drugs Trends

Increasing awareness about reproductive health and family planning
Growing demand for long-acting reversible contraceptives (LARCs)
Rising prevalence of sexually transmitted infections (STIs)
Expansion of telemedicine and online platforms for contraceptive counseling and prescription

Contraceptive Drugs Market Market Size and Forecast (2024-2030) — Contraceptive Drugs Market Company Market Share

Driving Forces: What's Propelling the Contraceptive Drugs Market

Government Initiatives and Policies: Continued government support through funding for programs, insurance coverage expansion, and comprehensive sex education drives market growth.
Technological Advancements: Innovations such as long-acting reversible contraceptives (LARCs), self-injectable contraceptives, and mobile health (mHealth) platforms enhance convenience, accessibility, and adherence.
Socioeconomic Factors: Urbanization, increased education, and improved economic status contribute to a preference for modern contraceptive methods and a shift towards family planning.
Health and Economic Benefits: Growing awareness of the consequences of unplanned pregnancies, including health risks and financial burdens, fuels the demand for effective contraceptives.
International Development and Global Health: Global initiatives prioritize access to contraception as a crucial component of sexual and reproductive health and overall well-being, driving market growth in developing countries.
Rising Demand in Emerging Markets: Expanding populations and increasing disposable incomes in emerging markets create significant growth opportunities for contraceptive drugs.

Challenges and Restraints in the Contraceptive Drugs Market

Side effects and safety concerns associated with certain contraceptives
Cultural and religious beliefs influencing contraceptive use in certain regions
Limited access to contraceptives in remote areas and underserved communities
Lack of comprehensive sex education in some countries

Emerging Trends in Contraceptive Drugs

Development of novel contraception technologies, such as non-hormonal methods
Integration of artificial intelligence (AI) and machine learning for personalized contraceptive recommendations
Telehealth services offering remote access to contraceptive care
Increasing use of smart devices for contraceptive tracking and management

Growth Catalysts in the Contraceptive Drugs Industry

Partnerships between pharmaceutical companies and non-profit organizations
Government funding for research and development of innovative contraceptives
Regulatory approvals for new contraceptive drugs and devices
Growing investment in clinical trials and product development

Market Segmentation: Contraceptive Drugs Analysis

Product:

Oral (Combined Contraceptives and Progestin-only Pills)
Injectables
Implants
Intrauterine Devices (IUDs)
Emergency Contraception

Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channels
Public Channels & NGOs
Others

Leading Players in the Contraceptive Drugs Market

Piramal Enterprises Ltd. (India)
Agile Therapeutics (U.S.)
Johnson & Johnson Services, Inc. (U.S.)
AbbVie Inc. (U.S.)
Pfizer Inc. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)

Significant Developments in the Contraceptive Drugs Sector

2021: FDA approval of Phexxi, a non-hormonal contraceptive gel
2022: Launch of the Sayana Press Injectable, a progestin-only contraceptive injection
2022: Partnership between Pathfinder International and FHI 360 to expand access to contraceptives in developing countries

Comprehensive Coverage Contraceptive Drugs Market Report

This report provides:

Comprehensive analysis of the global contraceptive drugs market
Detailed insights into key trends, drivers, and challenges
Market size and growth projections for different segments of the market
Profiles of leading players in the industry
Emerging technologies and growth opportunities in the market
Regional analysis of the market
Impact of COVID-19 on the market

Regional Insight

North America: Dominates the market with the highest adoption of modern contraceptives
Europe: Strong market with government support for family planning programs
Asia-Pacific: Rapidly growing market with increasing awareness and access to contraception
Latin America: Growing demand for long-acting reversible contraceptives
Middle East and Africa: Challenges in contraceptive access and use

Contraceptive Drugs Market Market Share by Region - Global Geographic Distribution — Contraceptive Drugs Market Regional Market Share

Pricing Analysis

Analysis of pricing strategies of key players
Impact of raw material costs and production expenses
Price segmentation based on product type and distribution channels

Import and Export Analysis

Key import and export markets for contraceptive drugs
Trade policies and regulations affecting the market
Analysis of major trading partners and their trade volume

Segmentation

Segmentation of the market based on product, distribution channel, region, and end-user
Detailed insights into each segment's size, growth potential, and competitive landscape

Patent/Trademark Analysis

Analysis of key patents and trademarks related to contraceptive drugs
Strategies employed by pharmaceutical companies to protect their intellectual property
Impact of patent expirations and generic drug development

Geographic Coverage of Contraceptive Drugs Market

Higher Coverage

Lower Coverage

No Coverage

Contraceptive Drugs Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 7.7% from 2020-2034
Segmentation	By Product Oral (Combined Contraceptives Progestin-only Pills By Distribution Channel Hospital Pharmacy Retail Pharmacy Clinics Online Channels Public Channels & NGOs Others By Geography North America U.S. Canada

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Growing Awareness Regarding Contraceptive Drugs Leads to Product Demand
- - 3.3. Market Restrains
  - - 3.3.1. Side Effects Associated with Drugs to Limit Product Demand
- - 3.4. Market Trends
  - - 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. Global Contraceptive Drugs Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product
  - 5.1.1. Oral (Combined Contraceptives
  - 5.1.2. Progestin-only Pills
- 5.2. Market Analysis, Insights and Forecast - by Distribution Channel
  - 5.2.1. Hospital Pharmacy
  - 5.2.2. Retail Pharmacy
  - 5.2.3. Clinics
  - 5.2.4. Online Channels
  - 5.2.5. Public Channels & NGOs
  - 5.2.6. Others
- 5.3. Market Analysis, Insights and Forecast - by Region
  - 5.3.1. North America
6. Competitive Analysis
- 6.1. Global Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 Piramal Enterprises Ltd. (India)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Agile Therapeutics (U.S.)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Johnson & Johnson Services Inc. (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 AbbVie Inc. (U.S.)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Pfizer Inc. (U.S.)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Teva Pharmaceutical Industries Ltd. (Israel)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Viatris Inc. (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 Amneal Pharmaceuticals Inc. (U.S.)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 Bayer AG (Germany)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)

List of Figures

Figure 1: Global Contraceptive Drugs Market Revenue Breakdown (USD billion, %) by Region 2025 & 2033
Figure 2: Global Contraceptive Drugs Market Volume Breakdown (K Tons, %) by Region 2025 & 2033
Figure 3: North America Contraceptive Drugs Market Revenue (USD billion), by Product 2025 & 2033
Figure 4: North America Contraceptive Drugs Market Volume (K Tons), by Product 2025 & 2033
Figure 5: North America Contraceptive Drugs Market Revenue Share (%), by Product 2025 & 2033
Figure 6: North America Contraceptive Drugs Market Volume Share (%), by Product 2025 & 2033
Figure 7: North America Contraceptive Drugs Market Revenue (USD billion), by Distribution Channel 2025 & 2033
Figure 8: North America Contraceptive Drugs Market Volume (K Tons), by Distribution Channel 2025 & 2033
Figure 9: North America Contraceptive Drugs Market Revenue Share (%), by Distribution Channel 2025 & 2033
Figure 10: North America Contraceptive Drugs Market Volume Share (%), by Distribution Channel 2025 & 2033
Figure 11: North America Contraceptive Drugs Market Revenue (USD billion), by Country 2025 & 2033
Figure 12: North America Contraceptive Drugs Market Volume (K Tons), by Country 2025 & 2033
Figure 13: North America Contraceptive Drugs Market Revenue Share (%), by Country 2025 & 2033
Figure 14: North America Contraceptive Drugs Market Volume Share (%), by Country 2025 & 2033

List of Tables

Table 1: Global Contraceptive Drugs Market Revenue USD billion Forecast, by Product 2020 & 2033
Table 2: Global Contraceptive Drugs Market Volume K Tons Forecast, by Product 2020 & 2033
Table 3: Global Contraceptive Drugs Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
Table 4: Global Contraceptive Drugs Market Volume K Tons Forecast, by Distribution Channel 2020 & 2033
Table 5: Global Contraceptive Drugs Market Revenue USD billion Forecast, by Region 2020 & 2033
Table 6: Global Contraceptive Drugs Market Volume K Tons Forecast, by Region 2020 & 2033
Table 7: Global Contraceptive Drugs Market Revenue USD billion Forecast, by Product 2020 & 2033
Table 8: Global Contraceptive Drugs Market Volume K Tons Forecast, by Product 2020 & 2033
Table 9: Global Contraceptive Drugs Market Revenue USD billion Forecast, by Distribution Channel 2020 & 2033
Table 10: Global Contraceptive Drugs Market Volume K Tons Forecast, by Distribution Channel 2020 & 2033
Table 11: Global Contraceptive Drugs Market Revenue USD billion Forecast, by Country 2020 & 2033
Table 12: Global Contraceptive Drugs Market Volume K Tons Forecast, by Country 2020 & 2033
Table 13: U.S. Contraceptive Drugs Market Revenue (USD billion) Forecast, by Application 2020 & 2033
Table 14: U.S. Contraceptive Drugs Market Volume (K Tons) Forecast, by Application 2020 & 2033
Table 15: Canada Contraceptive Drugs Market Revenue (USD billion) Forecast, by Application 2020 & 2033
Table 16: Canada Contraceptive Drugs Market Volume (K Tons) Forecast, by Application 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the Contraceptive Drugs Market?

The projected CAGR is approximately 7.7%.

2. Which companies are prominent players in the Contraceptive Drugs Market?

Key companies in the market include Piramal Enterprises Ltd. (India), Agile Therapeutics (U.S.), Johnson & Johnson Services, Inc. (U.S.), AbbVie Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Viatris Inc. (U.S.), Amneal Pharmaceuticals, Inc. (U.S.), Bayer AG (Germany).

3. What are the main segments of the Contraceptive Drugs Market?

The market segments include Product, Distribution Channel.

4. Can you provide details about the market size?

The market size is estimated to be USD 17.50 USD billion as of 2022.

5. What are some drivers contributing to market growth?

Growing Awareness Regarding Contraceptive Drugs Leads to Product Demand.

6. What are the notable trends driving market growth?

Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

7. Are there any restraints impacting market growth?

Side Effects Associated with Drugs to Limit Product Demand.

8. Can you provide examples of recent developments in the market?

N/A

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4850, USD 5850, and USD 6850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD billion and volume, measured in K Tons.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Contraceptive Drugs Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the Contraceptive Drugs Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the Contraceptive Drugs Market?

To stay informed about further developments, trends, and reports in the Contraceptive Drugs Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Related Reports

U.S. Contraceptive Drugs Market Strategic Roadmap: Analysis and Forecasts 2025-2033

Hormonal Contraceptives Market Strategic Roadmap: Analysis and Forecasts 2025-2033

Contraceptives Market 2025-2033 Analysis: Trends, Competitor Dynamics, and Growth Opportunities

Contraceptive Pills Market Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

Contraceptive Devices Market Is Set To Reach 7,013.8 Million By 2033, Growing At A CAGR Of XXX

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report